Mycoplasma pneumonia risk factors: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) |
YazanDaaboul (talk | contribs) |
||
| Line 8: | Line 8: | ||
Risk factors in the development of ''Mycoplasma'' pneumonia include the following: | Risk factors in the development of ''Mycoplasma'' pneumonia include the following: | ||
*Individuals between 5 and 40 years of age | *Individuals between 5 and 40 years of age | ||
:*''Mycoplasma'' pneumonia is | :*''Mycoplasma'' pneumonia is less common (but still incident) among children < 5 years of age or adults > 40-60 years of age. | ||
:*Elderly individuals are at increased risk of developing ''Mycoplasma'' pneumonia-related complications. | |||
*Individuals in closed communities | *Individuals in closed communities | ||
:*Healthcare setting | :*Healthcare setting | ||
Revision as of 23:47, 7 February 2016
|
Mycoplasma pneumonia Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mycoplasma pneumonia risk factors On the Web |
|
American Roentgen Ray Society Images of Mycoplasma pneumonia risk factors |
|
Risk calculators and risk factors for Mycoplasma pneumonia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Risk factors in the development of Mycoplasma pneumonia include age between 5-40 years, living in closed communities (healthcare settings, prisoners, military, college students), active lung disease, immunocompromised status, history of sickle cell disease, and active smoking.
Risk Factors
Risk factors in the development of Mycoplasma pneumonia include the following:
- Individuals between 5 and 40 years of age
- Mycoplasma pneumonia is less common (but still incident) among children < 5 years of age or adults > 40-60 years of age.
- Elderly individuals are at increased risk of developing Mycoplasma pneumonia-related complications.
- Individuals in closed communities
- Healthcare setting
- Prisoners
- Military
- College dormitories
- Active smoking status
- Active lung disease
- Patients with sickle cell disease
- Immunocompromised status